| Systemic human ILC precursors provide a substrate for tissue ILC differentiation AI Lim, Y Li, S Lopez-Lastra, R Stadhouders, F Paul, A Casrouge, ... Cell 168 (6), 1086-1100. e10, 2017 | 465 | 2017 |
| Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. JM Sallenave, J Shulmann, J Crossley, M Jordana, J Gauldie American journal of respiratory cell and molecular biology 11 (6), 733-741, 1994 | 370 | 1994 |
| SLPI and elafin: one glove, many fingers SE Williams, TI Brown, A Roghanian, JM Sallenave Clinical science 110 (1), 21-35, 2006 | 350 | 2006 |
| Expression of natural antimicrobials by human placenta and fetal membranes AE King, A Paltoo, RW Kelly, JM Sallenave, AD Bocking, JRG Challis Placenta 28 (2-3), 161-169, 2007 | 297 | 2007 |
| Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis JP Motta, LG Bermúdez-Humarán, C Deraison, L Martin, C Rolland, ... Science translational medicine 4 (158), 158ra144-158ra144, 2012 | 255 | 2012 |
| Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens AJ Simpson, AI Maxwell, JRW Govan, C Haslett, JM Sallenave FEBS letters 452 (3), 309-313, 1999 | 239 | 1999 |
| Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs C Ehre, EN Worthington, RM Liesman, BR Grubb, D Barbier, WK O’Neal, ... Proceedings of the National Academy of Sciences 109 (41), 16528-16533, 2012 | 208 | 2012 |
| IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex Q Espinassous, E Garcia-de-Paco, I Garcia-Verdugo, M Synguelakis, ... The Journal of Immunology 183 (2), 1446-1455, 2009 | 198 | 2009 |
| The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease JM Sallenave Respiratory research 1, 1-6, 2000 | 195 | 2000 |
| Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-κB-dependent inflammatory responses of human endothelial cells and macrophages to … PA Henriksen, M Hitt, Z Xing, J Wang, C Haslett, RA Riemersma, ... The Journal of Immunology 172 (7), 4535-4544, 2004 | 188 | 2004 |
| Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils JM Sallenave, M Si-Ta har, G Cox, M Chignard, J Gauldie Journal of leukocyte biology 61 (6), 695-702, 1997 | 185 | 1997 |
| Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity JM Sallenave American journal of respiratory cell and molecular biology 42 (6), 635-643, 2010 | 154 | 2010 |
| Antimicrobial activity of antiproteinases JM Sallenave Biochemical Society Transactions 30 (2), 111-115, 2002 | 153 | 2002 |
| Innate immune defences in the human uterus during pregnancy AE King, RW Kelly, JM Sallenave, AD Bocking, JRG Challis Placenta 28 (11-12), 1099-1106, 2007 | 151 | 2007 |
| Diagnostic importance of pulmonary interleukin-1β and interleukin-8 in ventilator-associated pneumonia AC Morris, K Kefala, TS Wilkinson, OL Moncayo-Nieto, K Dhaliwal, ... Thorax 65 (3), 201-207, 2010 | 144 | 2010 |
| Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis Z Xing, CT McFarland, JM Sallenave, A Izzo, J Wang, DN McMurray PloS one 4 (6), e5856, 2009 | 144 | 2009 |
| Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis JP Motta, L Magne, D Descamps, C Rolland, C Squarzoni–Dale, ... Gastroenterology 140 (4), 1272-1282, 2011 | 140 | 2011 |
| Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci LG Bermúdez-Humarán, JP Motta, C Aubry, P Kharrat, L Rous-Martin, ... Microbial cell factories 14, 1-11, 2015 | 136 | 2015 |
| C5a mediates peripheral blood neutrophil dysfunction in critically ill patients A Conway Morris, K Kefala, TS Wilkinson, K Dhaliwal, L Farrell, T Walsh, ... American journal of respiratory and critical care medicine 180 (1), 19-28, 2009 | 133 | 2009 |
| Innate immune signaling and proteolytic pathways in the resolution or exacerbation of SARS-CoV-2 in Covid-19: key therapeutic targets? JM Sallenave, L Guillot Frontiers in immunology 11, 550828, 2020 | 130 | 2020 |
